Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Variants of Interleukin-16 Associated with Gastric Cancer Risk

  • Zhang, Tao (Department of Gastrointestinal Surgery, the Centre Hospital of Wuhan) ;
  • Wang, Hui (Department of Gastrointestinal Surgery, the Centre Hospital of Wuhan)
  • Published : 2013.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Aim: We conducted a case-control matched study to investigate the role of IL-16 gene polymorphisms, rs4072111, rs1131445, rs4778889 and rs11556218, in the risk of gastric cancer in a Chinese population, also performing subgroup analysis by subsites. Methods: To test the hypothesis of involvement, we analyzed the four SNPs of IL16 in 347 cancer patients and 368 controls. Demographic data and other information were collected using a newly designed questionnaire. Genotyping of IL16 (rs4072111, rs1131445, rs4778889 and rs11556218) was performed in a 384-well plate format on the MassARRAY(R) platform. Results: In our study, we found the gastric cancer patients were more likely to be male and have a family history of cancer (P<0.05). We found the rs4778889 CC and rs11556218 GG genotype was significantly associated with 1.97 and 1.84-fold increased risk of non-cardia gastric cancer, while we did not find significant association between the four IL-16 SNPs and cardia gastric cancer. Conclusions: In conclusion, our study indicated that IL-16 rs4778889 CC and rs11556218 GG genotypes are associated with an increased risk of non-cardia gastric cancer in a Chinese population. Our results offer insights into the influence of IL-16 on development of gastric cancer.

Keywords

References

  1. Yonemoto N, Furuse J, Okusaka T, et al (2007). A multi-center retrospective analysis of survival benefits of chemotherapy for unresectable biliary tract cancer. Jpn J Clin Oncol, 37, 843-51. https://doi.org/10.1093/jjco/hym116
  2. Baier M, Bannert N, Werner A, et al (1997). Molecular cloning, sequence, expression, and processing of the interleukin 16 precursor. Proc Natl Acad Sci U S A, 94, 5273-7. https://doi.org/10.1073/pnas.94.10.5273
  3. Batai K, Shah E, Murphy AB, et al (2012). Fine-mapping of IL16 gene and prostate cancer risk in African Americans. Cancer Epidemiol Biomarkers Prev, 21, 2059-68. https://doi.org/10.1158/1055-9965.EPI-12-0707
  4. Chung YC, Chang YF (2003). Serum interleukin-6 levels reflect the disease status of colorectal cancer. J Surg Oncol, 83, 222-6. https://doi.org/10.1002/jso.10269
  5. Drwinga HL, Toji LH, Kim CH, et al (1993). NIGMS human/ rodent somatic cell hybrid mapping panels 1 and 2. Genomics, 16, 311-4. https://doi.org/10.1006/geno.1993.1190
  6. Gao LB, Liang WB, Xue H, et al (2009b). Genetic polymorphism of interleukin-16 and risk of nasopharyngeal carcinoma. Clin Chim Acta, 409, 132-5. https://doi.org/10.1016/j.cca.2009.09.017
  7. Gao LB, Rao L, Wang YY, et al (2009a). The association of interleukin-16 polymorphisms with IL-16 serum levels and risk of colorectal and gastric cancer. Carcinogenesis, 30, 295-9.
  8. Ghoshal UC, Tiwari S, Dhingra S, et al (2008). Frequency of Helicobacter pylori and CagA antibody in patients with gastric neoplasm and controls: the Indian enigma. Dig Dis Sci, 53, 1215-22. https://doi.org/10.1007/s10620-008-0229-7
  9. Ghoshal UC, Tripathi S, Ghoshal U (2007). The Indian enigma of frequent H. pylori infection but infrequent gastric cancer: is the magic key in Indian diet, host's genetic make up, or friendly bug? Am J Gastroenterol, 102, 2113-4. https://doi.org/10.1111/j.1572-0241.2007.01324_13.x
  10. Graham DY, Adam E, Reddy GT, et al (1991). Seroepidemiology of Helicobacter pylori infection in India; comparison of developing and developing countries. Dig Dis Sci, 36, 1084-8. https://doi.org/10.1007/BF01297451
  11. Gu XJ, Cui B, Zhao ZF, et al (2008). Association of the interleukin (IL)-16 gene polymorphisms with Graves' disease. Clin Immunol, 127, 298-302. https://doi.org/10.1016/j.clim.2008.01.017
  12. Huang H, Zeng Z, Zhang L, et al (2013). The association of interleukin-16 gene polymorphisms with susceptibility of coronary artery disease. Clin Biochem, 46, 241-4. https://doi.org/10.1016/j.clinbiochem.2012.11.009
  13. International Agency for Research on Cancer (2008). Globocan 2008: Stomach Cancer incidence, Mortality and Prevalence Worldwide in 2008. IARC.
  14. Kai H, Kitadai Y, Kodama M, et al (2005). Involvement of proinflammatory cytokines IL-1beta and IL-6 in progression of human gastric carcinoma. Anticancer Res, 25, 709-13.
  15. Liebrich M, Guo LH, Schluesener HJ, et al (2007). Expression of interleukin-16 by tumor-associated macrophages/activated microglia in high-grade astrocytic brain tumors. Arch Immunol Ther Exp (Warsz), 55, 41-7. https://doi.org/10.1007/s00005-007-0003-0
  16. Li S, Deng Y, Chen ZP, et al (2011). Genetic polymorphism of interleukin-16 influences susceptibility to HBV-related hepatocellular carcinoma in a Chinese population. Infect Genet Evol, 11, 2083-8. https://doi.org/10.1016/j.meegid.2011.09.025
  17. Mahindra A, Anderson KC (2012). Role of interleukin 16 in multiple myeloma pathogenesis: a potential novel therapeutic target? J Natl Cancer Inst, 104, 964-5. https://doi.org/10.1093/jnci/djs274
  18. Mathy NL, Scheuer W, Lanzendorfer M, et al (2000). Interleukin-16 stimulates the expression and production of pro-inflammatory cytokines by human monocytes. Immunology, 100, 63-9. https://doi.org/10.1046/j.1365-2567.2000.00997.x
  19. Milke L, Schulz K, Weigert A, et al (2013). Depletion of tristetraprolin in breast cancer cells increases interleukin-16 expression and promotes tumor infiltration with monocytes/ macrophages. Carcinogenesis, 34, 850-7. https://doi.org/10.1093/carcin/bgs387
  20. Nakayama EE, Wasi C, Ajisawa A, et al (2000). A new polymorphism in the promoter region of the human interleukin-16 (IL-16) gene. Genes Immun, 1, 293-4. https://doi.org/10.1038/sj.gene.6363672
  21. Ni P, Xu H, Xue H, et al (2012). A meta-analysis of interleukin-10-1082 promoter polymorphism associated with gastric cancer risk. DNA Cell Biol, 31, 582-91. https://doi.org/10.1089/dna.2011.1440
  22. Parsonnet J, Friedman GD, Orentreich N, et al (1997). Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut, 40, 297-301. https://doi.org/10.1136/gut.40.3.297
  23. Salazar-Onfray F, Lopez MN, Mendoza-Naranjo A (2007). Paradoxical effects of cytokines in tumor immune surveillance and tumor immune escape. Cytokine Growth Factor Rev, 18, 171-82. https://doi.org/10.1016/j.cytogfr.2007.01.015
  24. Schneider MR, Hoeflich A, Fischer JR, et al (2000). Interleukin-6 stimulates clonogenic growth of primary and metastatic human colon carcinoma cells. Cancer Lett, 151, 31-8. https://doi.org/10.1016/S0304-3835(99)00401-2
  25. Shanmugham LN, Petrarca C, Frydas S, et al (2006). IL-15 an immunoregulatory and anti-cancer cytokine. Recent advances. J Exp Clin Cancer Res, 25, 529-36.
  26. Thomas G, Jacobs KB, Yeager M, et al (2008). Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet, 40, 310-5. https://doi.org/10.1038/ng.91
  27. Wu J, Wang Y, Zhang Y, Li L (2011). Association between interleukin-16 polymorphisms and risk of coronary artery disease. DNA Cell Biol, 30, 305-8. https://doi.org/10.1089/dna.2010.1145
  28. Xue H, Lin B, An J, et al (2012). Interleukin-10-819 promoter polymorphism in association with gastric cancer risk. BMC Cancer, 12, 102. https://doi.org/10.1186/1471-2407-12-102
  29. Yellapa A, Bahr JM, Bitterman P, et al (2012). Association of interleukin 16 with the development of ovarian tumor and tumor-associated neoangiogenesis in laying hen model of spontaneous ovarian cancer. Int J Gynecol Cancer, 22, 199-207. https://doi.org/10.1097/IGC.0b013e318236a27b
  30. Yuzhalin A (2011). The role of interleukin DNA polymorphisms in gastric cancer. Hum Immunol, 72, 1128-36. https://doi.org/10.1016/j.humimm.2011.08.003
  31. Zhang Y, Center DM, Wu DM, et al (1998). Processing and activation of pro-interleukin-16 by caspase-3. J Biol Chem, 273, 1144-9. https://doi.org/10.1074/jbc.273.2.1144

Cited by

  1. Interleukin-12 and Interleukin-6 Gene Polymorphisms and Risk of Bladder Cancer in the Iranian Population vol.15, pp.18, 2014, https://doi.org/10.7314/APJCP.2014.15.18.7869
  2. Genetic Polymorphisms of Interleukin-16 and Risk of Knee Osteoarthritis vol.10, pp.5, 2015, https://doi.org/10.1371/journal.pone.0123442
  3. Interleukin-16 polymorphisms as new promising biomarkers for risk of gastric cancer vol.37, pp.2, 2016, https://doi.org/10.1007/s13277-015-4013-y
  4. Association of genetic polymorphisms of interleukins with gastric cancer and precancerous gastric lesions in a high-risk Chinese population vol.37, pp.2, 2016, https://doi.org/10.1007/s13277-015-4022-x
  5. Association of interleukin-16 polymorphisms with disease progression and susceptibility in endometriosis vol.43, pp.5, 2016, https://doi.org/10.1111/iji.12281
  6. The expression of IGF-1R in Helicobacter pylori-infected intestinal metaplasia and gastric cancer vol.59, pp.1, 2016, https://doi.org/10.3164/jcbn.16-11
  7. Interleukin-16 Polymorphism Is Associated with an Increased Risk of Glioma vol.18, pp.10, 2014, https://doi.org/10.1089/gtmb.2014.0170
  8. Diagnostic and prognostic value of serum interleukin-16 in patients with gastric cancer vol.16, pp.6, 2017, https://doi.org/10.3892/mmr.2017.7688